TAKEDA PHARMACEUTICALS NORTH AMERICA INC has a total of 20 patent applications. Its first patent ever was published in 2007. It filed its patents most often in China, Brazil and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and machines are SHENYANG YIXINYUAN BIOTECHNOLOGY CO LTD, ORGANEXT RES B V and TSUJI AKIRA.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | Brazil | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 | |
#5 | Argentina | 1 | |
#6 | Chile | 1 | |
#7 | Hong Kong | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | Taiwan | 1 | |
#12 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Vakilynejad Majid | 7 |
#2 | Taneja Rajneesh | 7 |
#3 | Gupte Vijay | 5 |
#4 | Atkinson Stuart | 4 |
#5 | Lademacher Christopher | 4 |
#6 | Gunawardhana Lhanoo | 4 |
#7 | Mulford Darcy | 4 |
#8 | Macdonald Patricia | 3 |
#9 | Naik Himanshu | 3 |
#10 | Lee Ronald L | 3 |
Publication | Filing date | Title |
---|---|---|
US2010311756A1 | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof |